Metagenomix is an early-stage biotechnology company developing novel methods of screening microbes for pharmacologically active compounds. Among the indications under investigation are cancer, inflammation and infectious diseases including fungal infections and malaria. The technology also has applications in agriculture.
Funding Rounds (1) - $700kUpdate
Current Team (1)Update
|Jul 6, 2010||Hartford Business - CT invests $350K in Branford biotech startup|